51
Growth Score in past quarter
pts
Heat Score 51 in past quarter
49 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
306765
Sonorous develops minimally invasive venous stent systems to treat symptomatic cerebral venous diseases and pulsatile tinnitus.
- Joel Harris: President & CEO
About the Company
Sonorous develops minimally invasive medical devices for patients with symptomatic cerebral venous diseases. The company focuses on venous stent systems designed to normalize intracranial venous blood flow and pressure. Its technology targets conditions such as pulsatile tinnitus, intracranial venous stenosis, and related headaches and auditory
symptoms. Solutions include a self-expandable scaffold navigated to cerebral venous sinus stenosis to improve drainage and reduce turbulent flow. Sonorous works with neurovascular and interventional physicians to improve patient quality of life.